Research / AIRI / Fundamental state Inspectable configuration
State dimensions Filing 0001213900-26-088334 General Corporate
Debt relative to revenue 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
213.74% · OPTIONAL · VALID
Capex intensity 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.50% · OPTIONAL · VALID
Operating cash generation 90th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
12.70% · OPTIONAL · VALID
Revenue growth 50th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-5.25% · CORE · VALID
Inventory pressure 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
305.95% · OPTIONAL · VALID
Gross margin 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
20.70% · CORE · VALID
Operating margin 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-3.05% · CORE · VALID
SBC intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.49% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 58 states Self-history eligible
Jun 30, 2021 8/8 normalized Level 3 Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Sep 30, 2024 5/5 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 48.19%
Current 213.74%
Delta 165.55% Capex Intensity Decreased
Previous 3.66%
Current 0.50%
Delta -3.16% Cash Generation Increased
Previous -11.18%
Current 12.70%
Delta 23.88% Growth Decreased
Previous -4.36%
Current -5.25%
Delta -0.89% Inventory Pressure Increased
Previous 304.00%
Current 305.95%
Delta 1.95% Margin Decreased
Previous 22.42%
Current 20.70%
Delta -1.72% Profitability Increased
Previous -4.87%
Current -3.05%
Delta 1.82% Sbc Intensity Decreased
Previous 8.31%
Current 0.49%
Delta -7.81% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Sep 30, 2024
Similarity 72%
Compared 5 dimensions
Coverage 63% Growth 15.0 · Margin 40.0 · Profitability 35.0 · Inventory Pressure 25.0 · Balance Sheet Leverage 15.0 Mar 31, 2015
Similarity 69%
Compared 6 dimensions
Coverage 75% Margin 1.1 · Profitability 7.2 · Capex Intensity 55.6 · Cash Generation 34.4 · Inventory Pressure 39.4 · Balance Sheet Leverage 5.0 Jun 30, 2023
Similarity 66%
Compared 7 dimensions
Coverage 88% Growth 0.0 · Margin 25.0 · Profitability 35.0 · Sbc Intensity 25.0 · Capex Intensity 65.0 · Cash Generation 35.0 · Inventory Pressure 20.0 Mar 31, 2020
Similarity 64%
Compared 8 dimensions
Coverage 100% Growth 0.0 · Margin 55.0 · Profitability 35.0 · Sbc Intensity 55.0 · Capex Intensity 15.0 · Cash Generation 35.0 · Inventory Pressure 40.0 · Balance Sheet Leverage 5.0 Mar 31, 2024
Similarity 63%
Compared 8 dimensions
Coverage 100% Growth 25.0 · Margin 65.0 · Profitability 0.0 · Sbc Intensity 0.0 · Capex Intensity 15.0 · Cash Generation 50.0 · Inventory Pressure 55.0 · Balance Sheet Leverage 15.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.